Concepedia

Long-term Follow-up Study of Ingenol Mebutate Gel for the Treatment of Actinic Keratoses

Mark Lebwohl, Stephen Shumack, Linda Stein Gold, Anita E. Melgaard, Thomas Larsson, Stephen K. Tyring

JAMA Dermatology · 2013 · 138 citations · 9 references

DOI

Abstract

Ingenol mebutate gel applied as field therapy for 2 or 3 consecutive days to treat actinic keratoses produced clinically relevant sustained clearance and long-term lesion reduction. TRIAL REGISTRATION clinicaltrials.gov Identifiers: NCT00953732, NCT00952783, and NCT00989313.

References

9

Ingenol Mebutate Gel for Actinic Keratosis

Mark Lebwohl, Neil A. Swanson, Lawrence L. Anderson et al. · New England Journal of Medicine · 2012 · 464 citations · Full text

A randomised study of topical 5% imiquimod vs. topical 5-fluorouracil vs. cryosurgery in immunocompetent patients with actinic keratoses: a comparison of clinical and histological outcomes including 1-year follow-up

N. Krawtchenko, J. Roewert-Huber, Ida Mann et al. · British Journal of Dermatology · 2007 · 251 citations

Clinical, histopathological and immunohistochemical assessment of human skin field cancerization before and after photodynamic therapy

Rolf‐Markus Szeimies, Luís Torezan, Ane Beatriz Mautari Niwa et al. · British Journal of Dermatology · 2012 · 137 citations

Vehicle-controlled, double-blind, randomized study of imiquimod 5% cream applied 3 days per week in one or two courses of treatment for actinic keratoses on the head

Joseph L. Jorizzo, Scott M. Dinehart, Robert Matheson et al. · Journal of the American Academy of Dermatology · 2007 · 117 citations

, , +6

Long-Term Clinical Outcomes Following Treatment of Actinic Keratosis with Imiquimod 5% Cream

Peter K. Lee, William B. Harwell, Keith H. Loven et al. · Dermatologic Surgery · 2006 · 44 citations